Clinical trial
A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia
NCT01129531 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- January 31, 2012
- Enrollment
- 294 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.